Article
Development of recombinant human prolactin receptor antagonists by molecular mimicry of the phosphorylated hormone.
Endocrinology - 1 Feb 1998
Chen T J, Kuo C B, Tsai K F, Liu J W, Chen D Y, Walker A M
Abstract excerpt
Previous studies have demonstrated that naturally phosphorylated PRL antagonizes the growth-promoting effects of unmodified PRL in two different PRL-responsive cell lines. In this study our aim was to produce a molecular mimic of phosphorylated PRL by substituting a fairly bulky, negatively charged amino acid (glutamate or aspartate) for the normally phosphorylated serine [serine 179 in human PRL (hPRL)]. In...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
